Details
Category: Volume 08 Issue 03 March 2020
Hits: 960

Title: Non-lipid risk factors with gender on the severity of metabolic syndrome

Authors: Dr V.Srinivasa Babu, Dr R. Vijayaraghavan, Dr C. Ramaswamy, Dr V. Mahalakshmamma, Dr B.S. Mohan, N. Hanumanth

 DOI: https://dx.doi.org/10.18535/jmscr/v8i3.81

Abstract

   

Background: It is recognized that inflammatory markers high sentive c-reactive protein, thyroid profile, and uric acid were collectively called as non-lipid risk factors also as added risks of metabolic syndrome (MS). There were sex-specific associations among various risk parameters in MS. A standardized incidence of MS in total was 24.2%, in that, 24.6% men and 23.8% women. A study existed the prevalence of SMS was 21.9% in adults aged 50 years, and in adolescents, it remains 8.0%. Also, women presented a higher incidence of SMS when compared to men aged <50 years, 76.3% women, and 20.7% men ≥50 years, 86.2% women, and 13.8% men.

Methods: A total of 450 participants (211 men and 239 women) aged ≥35 years divided into three groups (150 participants in each group), according to the number of parameters of MS risk factors. Group I: Subjects with less than any of the three components of MS (Control group), Group II: Subjects with any three variables of MS(MS group), Group III: Subjects with more than three components of MS(Severe MS group {SMS}). The data were analyzed by one-way ANOVA and with Student-Newman-Keul’s multiple comparison method.

Results: The value of non-lipid risk parameters hs-CRP in MS, and SMS groups in male found a high significance than Control (P<0.001), but not significant (P = 0.156) in the female. The value of UA found high significance value (P = 0.001) in male and highly significant than Control (P<0.001) in MS, and SMS in the female. The T3 of the Control group was, compared with MS, SMS groups, and not significant (P = 0.185) in males, was significant (P=0.039)in the female. In the case of thyroxin (T4), values were significantly high in males and females (P = 0.002 and P<0.001), respectively. TSH (µIU/mL) Control group was significantly high (P = 0.009) in male MS and SMS groups, but not significant (P = 0.913) in female.

Conclusion: The comparison of specific non-lipid risk parameters like high-sensitivity C-reactive protein, uric acid, triiodothyronine, thyroxin, and TSH in MS and SMS in males and females that significantly differed in MS and SMS than the normal.

Keywords: Metabolic syndrome; Non-lipid risks; hs-CRP; Uric acid; TSH.

References

  1. Supriya R, Yu AP, Lee PH, Lai CW, Cheng KK, Yau SY, Chan LW, Yung BY, Siu PM (2018). Yoga training modulates adipokinesin adults with high-normal blood pressure and metabolic syndrome. Scand J Med Sci Sports. 28:1130–1138.
  2. Cho DY and Koo JW (2018). Differences in Metabolic Syndrome Prevalence by Employment Type and Sex. Int J Environ Res Public Health. 15(9):1798.
  3. Li Y, Zhao L, Yu D, Wang Z, Ding G (2018). Metabolic syndrome prevalence andits risk factors among adults in China: A nationally representative cross sectional study. PLoSONE 13(6): e0199293.
  4. Martin S, Bouchard Danielle R, Dionne Isabelle J, Martin B (2012). Lifestyle Habits and Physical Capacity in Patients with Moderate or Severe Metabolic Syndrome. Metabolic Syndrome and Related Disorders. June,10(3):232-240.
  5. Han LL, Wang YX, Li J, Zhang XL, Bian C, Wang H, Du S, Suo LN (2014). Gender differences in associations of serum ferritin and diabetes, metabolic syndrome, and obesity in the China Health and Nutrition Mol    Nutr Food Res. 58(11):2189-95.
  6. Geer EB and Shen W (2009). Gender Differences in Insulin Resistance, Body Composition, and Energy Balance, Gen Med. 6(1): 60–75.
  7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979.
  8. Pradhan AD, Manson JE, Rifai N, Buring JE and Ridker PM (2001). C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus. JAMA. 286:327-334.
  9. Freeman DJ, Norrie J, Caslake MJ. Gaw A, Ford I, Lowe GD, O’Reilly DS, Packard CJ, and Sattar N (2002). C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51(5):1596-1600.
  10. Margit F, Nikolai M, Hartmut H, Armin I, Angela D, Mark BP, Wolfgang K (2003). Markers of inflammation in women on different hormone replacement therapies. Annals of Medicine. 35:5:353-361.
  11. Chiou WK, Wang MH, Huang DH, Chiu HT, Lee YJ, Lin JD (2010). The Relationship between Serum Uric Acid Level and Metabolic Syndrome: Differences by Sex and Age in Taiwanese. J Epidemiol. 20(3):219–224.
  12. Kawamoto Ryuichi, Tomita Hitomi, Oka Yuichiro and Ohtsuka Nobuyuki (2006). Relationship between Serum Uric Acid Concentration, Metabolic Syndrome and Carotid Atherosclerosis Internal Medicine. 45:9:605-614.
  13. Akram H.M Muhammad, Asif, Khan Usmanghani, Naveed Akhtar, Qaiser Jabeen, Asadullah Madni, Tariq saeed, Riazur Rehman, Khalil Ahmed and S.M Ali Shah (2011). Obesity and the risk of hyperuricemia in Gadap Town, Karachi. African Journal of Biotechnology. 10(6):996-998.
  14. Lin SD, Tsai DH, Hsu SR (2006). Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 69(11):512-6.
  15. Bauer DC, Ettinger B, Browner WS (1998). Thyroid functions and serum lipids in older women: a population-based study. Am J Med. 104(6):546-51.
  16. Garcia-Garduno JJ, Romero EC, Ochoa AL, Romero-Figueroa S, Bravo GH, García RT, Montenegro-Morales P, Mendieta-Zerón H (2015). Thyroid function is associated with insulin resistance markers in             healthy adolescents with risk factors to develop diabetes. Diabetol  Metab Syndr. 7:16.
  17. Roos A, Bakker SJL, Links TP, Gans ROB, Wolffenbuttel BHR (2007). Thyroid function is associated with components of metabolic syndrome. J Clin Endocrinol Metab. 92(2):491-6.
  18. Sudhakar MK, Agarwal G, Mohini singh, Senthil N, Rajendran A (2011). The prevalence of thyroid dysfunction among South Indian women with Metabolic Syndrome. Journal of Clinical and Diagnostic Research. Apr, 5(2):213-216.
  19. Alberti KG, Eckel, RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato, KA (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation; Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120(16):1640-5.
  20. Grundy S. M, Cleeman J. I, Daniels S. R., “Diagnosis and management of the metabolic syndrome: an American Heart Association/NationalHeart, Lung, and Blood institute scientific statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005.
  21. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D, Agostino RB Jr, Herrington DM. Gender and C-reactive protein (2006). Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. Sep. 152(3):593-8.
  22. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:836–843.
  23. Ridker PM, Buring JE, Cook NR, Rifai N (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardio-vascular events. Circulation. 107:391–397.
  24. Garcia VP, Rocha HNM, Sales ARK, Rocha NG, Nóbrega ACL (2016). Sex -Differences in High Sensitivity C-Reactive Protein in Subjects with Risk Factors of Metabolic Syndrome Arq Bras Cardiol. 106(3):182–187.
  25. Sah SK, Khatiwada S, Pandey S, Kc R, Das BK, Baral N, Lamsal M (2016). Association of high-sensitivity C-reactive protein and uric acid with the metabolic syndrome components. Springer plus. 5:269.
  26. Islam Safiqul Md, Islam Saiful Md, Yearul Kabir (2011). Association of C-reactive protein and uric acid with Type 2 diabetes. DUJBS. 20(2): 191-199.
  27. Nejatinamini S, Ataie-Jafari A, Qorbani M, Nikoohemat S, Kelishadi R, Asayesh H, Hosseini S (2015). Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord.Sep 14:70.
  28. Bhagyashree N, Ramaswamay C, Ganesh M (2016). A correlative study showing the relationship of salivary uric acid level with the metabolic syndrome components and its severity. Int J Applied Bio Phar Tech. 7(4):168-72.
  29. Garduno-Garcia JJ, Alvirde-Garcia U, Lope-Carrasco G, Padilla Mendoza ME (2010). TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 163:273-278.
  30. Lakshmi K, Sherry P, Arthur Ch (2017). Hypothyroidism and the Metabolic Syndrome. Endocrinology and Metabolism International Journal. 5(2):115-18.
  31. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D, Tountas N, Economopoulos T, Raptis SA, Dimitriadis G (2009). Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. European Journal of Endocrinology. 160:785-790.

Corresponding Author

Srinivasa Babu V

Assistant Professor, Department of Physiology, Nimra Institute of Medical Sciences and Research Foundation, Ibrahimpatnam, Vijayawada, Andhra Pradesh - 521456, INDIA